Hyperkalemia Risk of Finerenone Versus Spironolactone in CKD patients with type 2 Diabetes

Nephrol Dial Transplant. 2025 May 29:gfaf098. doi: 10.1093/ndt/gfaf098. Online ahead of print.

Abiodun Idowu¹, Kevin Bryan Lo², Olayinka Adebolu¹, Michael Hamilton¹, Peter Abdelmaseeh³, Sankar D Navaneethan^{4

5}, Janani Rangaswami^{6

7}

¹ Department of Medicine, Jefferson Einstein Hospital, Philadelphia, PA, USA.
² Department of Cardiology, Brigham and Women's Hospital, Boston, MA, USA.
³ Department of Cardiology, Jefferson Einstein Hospital, Philadelphia, PA, USA.
⁴ Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas; Institute of Clinical and Translational Research, Baylor College of Medicine, Houston, Texas.
⁵ Renal Section, Medical Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.
⁶ Washington DC VA Medical Center, Washington, DC, USA.
⁷ George Washington University School of Medicine, Washington, DC, USA.

No abstract available